Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
36.70
+1.71 (4.89%)
At close: Jun 26, 2026, 4:00 PM EDT
37.32
+0.62 (1.69%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Crinetics Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Crinetics Pharmaceuticals stock have an average target of 87.75, with a low estimate of 67 and a high estimate of 97. The average target predicts an increase of 139.10% from the current stock price of 36.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Crinetics Pharmaceuticals stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $95 | Buy | Maintains | $95 | +158.86% | Jun 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Reiterates $89 → $88 | Buy | Reiterates | $89 → $88 | +139.78% | May 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $87 → $84 | Buy | Maintains | $87 → $84 | +128.88% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $97 | Buy | Maintains | $97 | +164.31% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $83 | Buy | Maintains | $83 | +126.16% | May 8, 2026 |
Financial Forecast
Revenue This Year
68.29M
from 7.70M
Increased by 787.33%
Revenue Next Year
173.02M
from 68.29M
Increased by 153.36%
EPS This Year
-4.78
from -4.95
EPS Next Year
-4.21
from -4.78
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 76.1M | 215.9M | |
| Avg | 68.3M | 173.0M | |
| Low | 57.7M | 109.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 888.6% | 216.2% | |
| Avg | 787.3% | 153.4% | |
| Low | 650.2% | 60.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.87 | -3.38 | |
| Avg | -4.78 | -4.21 | |
| Low | -5.28 | -5.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.